Arcadia Biosciences, Inc. financial data

Symbol
RKDA on Nasdaq
Location
Dallas, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 383% % -12%
Quick Ratio 58% % 48%
Debt-to-equity 61% % 1.9%
Return On Equity -81% % -56%
Return On Assets -47% % -39%
Operating Margin -66% % -290%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,373,120 shares 0.6%
Common Stock, Shares, Outstanding 1,367,429 shares 0.18%
Entity Public Float $4,184,025 USD 0.36%
Common Stock, Value, Issued $65,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,367,192 shares 0.25%
Weighted Average Number of Shares Outstanding, Diluted 1,371,879 shares 0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,172,000 USD 16%
Research and Development Expense $22,000 USD -100%
Costs and Expenses $8,575,000 USD 65%
Operating Income (Loss) $3,403,000 USD -353%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,182,000 USD -85%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $5,067,000 USD 13%
Earnings Per Share, Basic -3 USD/shares -180%
Earnings Per Share, Diluted -3 USD/shares -180%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,120,000 USD -72%
Inventory, Net $1,457,000 USD 74%
Assets, Current $8,387,000 USD -22%
Property, Plant and Equipment, Net $10,000 USD -82%
Operating Lease, Right-of-Use Asset $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $39,000 USD 0%
Other Assets, Noncurrent $148,000 USD -9.8%
Assets $8,584,000 USD -44%
Employee-related Liabilities, Current $962,000 USD -14%
Liabilities, Current $2,285,000 USD -1.8%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $3,141,000 USD -38%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $279,881,000 USD -1.8%
Stockholders' Equity Attributable to Parent $6,223,000 USD -52%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5,443,000 USD -46%
Liabilities and Equity $8,584,000 USD -44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,588,000 USD 51%
Net Cash Provided by (Used in) Financing Activities $5,000,000 USD 0%
Net Cash Provided by (Used in) Investing Activities $500,000 USD -88%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 1,367,429 shares 0.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,083,000 USD 66%
Deferred Tax Assets, Valuation Allowance $28,370,000 USD -7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability $0 USD -100%
Depreciation $13,000 USD -71%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,184,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid $155,000 USD -85%
Property, Plant and Equipment, Gross $1,907,000 USD 0%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $155,000 USD -83%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -108%
Deferred Tax Assets, Operating Loss Carryforwards $25,336,000 USD 9.4%
Unrecognized Tax Benefits $0 USD
Deferred Tax Assets, Net of Valuation Allowance $28,438,000 USD -7.4%